AXDX

Accelerate Diagnostics
AXDX

Overview Fund Activity
Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

117 hedge funds and large institutions have $679M invested in Accelerate Diagnostics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
2.55%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
18
Increased
38
Reduced
24
Closed
12
Calls
$10.2M
Puts
$9.47M
Net Calls
+$734K
Net Calls Change
-$3.54M

Top Buyers

1
Axa
Axa
France
$40.3M
2
CWG
C WorldWide Group
Denmark
$12M
3
Fidelity Investments
Fidelity Investments
Massachusetts
$26.8M
4
BlackRock
BlackRock
New York
$45.9M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$5.47M

Top Sellers

1
AAMU
Amundi Asset Management US
Massachusetts
$2.13M
2
CCM
Cadian Capital Management
New York
$385K
3
JPMPWA
J.P. Morgan Private Wealth Advisors
California
$11.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
5
AG
Artal Group
Luxembourg
$10.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
126
Cubist Systematic Strategies
Connecticut
– -$14K -69 Closed
PFO
127
Pathstone Family Office
New Jersey
– -$3K -12 Closed
WEC
128
Winslow Evans & Crocker
Massachusetts
– -$2K -6 Closed
PHK
129
Point72 Hong Kong
Hong Kong
– -$1K -4 Closed
2 3 4 5
6